Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recurrence of Dupuytren's disease in the thumb after collagenase treatment
NL-OMON25315Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2015
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by University Medical Center Groningen. Primary endpoint: Increase in degrees of extension deficit in thumb or first webspace. Planned start Dec 2015; status: not yet recruiting.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on NL-OMON25315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25315.